Clinical evaluation study of newly developed Luminex-based all RAS mutation assay kit
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Primary outcome(s): Concordance rate of both KRAS and NRAS gene exon 2, 3 and 4 mutations between standard genetic testings including sanger sequencing and an established in vitro diagnostic (IVD) kit for KRAS exon2, and a newly developed Luminex-based all RAS assay kit
创建时间：
2013-09-15
